Polymyalgia Rheumatica

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

Polymyalgia rheumatica usually affects persons over the age of 60 years and the average age is 72 years and women are more affected than men. It is characterized by proximal myalgia of the shoulder and pelvic girdles accompanied by morning stiffness and nonspecific systemic symptoms. Bilateral subacromial subdeltoid bursitis is deemed to be a feature of PMR. About 16–21% of the patients with PMR develop giant cell arteritis (GCA) and about half the patients with GCA have associated PMR. PMR shows prompt and good response to corticosteroids.

Keywords

Polymyalgia rheumatic Giant cell arteritis PMR-like syndrome Bilateral subacromial subdeltoid bursitis 

References

  1. 1.
    Schmidt J, Warrington KJ. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological treatment. Drugs Aging. 2001;28(8):651–66.CrossRefGoogle Scholar
  2. 2.
    Salvarani C, Piptone N, Versan A, Hunder GG. Clinical features of polymyalgia rheumatic and giant cell arteritis. Rev Rheumatol. 2012;(9) 509–21.Google Scholar
  3. 3.
  4. 4.
    Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in tne United States. Arthritis Rheumat 2008;58(1):26–35.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mitchet CJ, Matteson EL. Polymyalgia rheumatic. BMJ. 2008;336:765–9.CrossRefGoogle Scholar
  6. 6.
    Vos PA, Bijlsma JW, Derksen RH. Polymyalgiarhrumatica and temporal arteritis. Ned Tijdschr Geneeskd. 2005;149(35):1932–7.PubMedGoogle Scholar
  7. 7.
    Uwin B, Williams CM, Gilliland W. Polymyalgia rheumatic and giant cell arteritis. Am Fam Physician. 2006;74(9):1547–54.Google Scholar
  8. 8.
    Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Lancet. 2008;372:234–45.CrossRefPubMedGoogle Scholar
  9. 9.
    Wilske KR, Healey LA. Polymalgia rheumatic and Giant call arteritis. The dilemma of therapy. Postgrad Med. 1985;77(8):243–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Chatelain D, Duhant P, Loire R, Bosshard S, Peket H, Piette TC, et al. Small vessel vasculitis surrounding inflamed temporal artery; a new diagnostic criterion for polymyalgia rheumatic. Arthritis Rheum. 2008;58(8):2565–73.CrossRefPubMedGoogle Scholar
  11. 11.
    Salvarani C, Gabriel S, Hunder GG,. Distal extremity swelling with pitting oedema in polymyalgia rheumatica. Report on nineteen cases. Arthritis Rheum. 1996;39:73–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Yurdakul FG, BodurH, Sivas F, Baskan B, Eser F, Yilmaz O. Clinical features treatment and monitoring in patients with polymyalgia rheumatic Arch Rheumatol. 2015;30:028–033.Google Scholar
  13. 13.
    Olivieri N, Pipitone N, D’Angelo S, Padula A, Salvarani C. Late-onset rheumatoid arthritis and late-onset spondyloarthrtiis. Clin Exp Rheumatol 2009; 27(Suppl55):S139–S145.PubMedGoogle Scholar
  14. 14.
    Olivieri I, Garcia-Porrua C, Padula A, Cantini F, Salvarani C, Gonzalez-Gay MA. Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int. 2007;27:927–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, et al. The clinical features if elderly onset rheumatoid arthritis: A comparison with younger onset disease of similar duration. Arthritis Rheum. 1985;28(9):987–94.CrossRefPubMedGoogle Scholar
  16. 16.
    Bajoochi G, La Corte R, Locaputo A, Govoni M, Trotta F. Elderly- onset rheumatoid arthritis: clinical aspects. Clin Exp Rheumatol. 2000;18(4 Suppl 20): S49–50.Google Scholar
  17. 17.
    Charlton R. Optimal management of giant cell arteritis and polymyalgia rheumatic. Ther Clin Risk Manag. 212;8:173–9.Google Scholar
  18. 18.
    Pease CT, Haugeberg G, Morgan AW, Montgue B, Hensor EM, Bhakta BB. Diagnosng late onset rheumatoid artheritis, polymyalgia rheumatic and temporal arteritis in pstients presenting with polymyalgic sympotoms. A prospective long term evaluation. J Rheumatol. 2005;32(6):1043–6.PubMedGoogle Scholar
  19. 19.
    Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, et al. Provisionsl classfication criteria for polymyalgia rheumatic: a European League Against Rheumatism/American college of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64:943–54.CrossRefPubMedGoogle Scholar
  20. 20.
    Kermani TA, Warrington KJ. Advances and challenges in the diagnosis and treatment of polymyalgia rheumatic. Ther Adv Musculoskelt Dis. 2014;6(1):8–19.CrossRefGoogle Scholar
  21. 21.
    Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rhematica: comparison with previous criteria ina single-centre study. Ann Rheum Dis 2014;73(6):1190–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Camellino D, Cimmino MA. Imaging of polymyalgia rheumstica: Indications in its pathogenesis diagnoss and prognosis. Rheumatology (Oxford). 2012;51:77–86.CrossRefPubMedGoogle Scholar
  23. 23.
    Lee J, Choi ST, Kim YS, Yoon BY, Kwok SK, Kim H, et al. Clinical characteristics and prognostic factors for relapse with polymyalgia rheumatic (PMR). Rheumatol Int. 2013;33: 78–86.Google Scholar
  24. 24.
    Kim HA, Lee J, HaYJ, Kin SH, Lu CH, Choi HY, et al. Induction of remission is difficult due to frequent relapse during tapering steroids in Korean pstints with polymyalgia rheumatica. J Korean Med Sci. 2012;27:224–6.CrossRefGoogle Scholar
  25. 25.
    Lundberg I, Hedfors E. Restricted dose and duration of corticosteroid treated patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1990;17:1340–5.PubMedGoogle Scholar
  26. 26.
    Salvarani C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castr C, et al. Polmyalgia rheumatica and giant cell arteritis : a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987;5:205–15.PubMedGoogle Scholar
  27. 27.
    Cimmino MA, Salvarani C, Macchioni L, Gerli R, Delle Monache F, Montecucco C, et al. Long term follow up of polymyalgia rheumatica patients treated with steroid with methotrexate and steroids. Clin Exp Rheumatol. 2008;26(3):395–400.Google Scholar
  28. 28.
    Gabriel SG, Sunku J, Salvarani C, O’Falon WM., Hunder CG. Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. 1997;40(10):1873–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations